OTC Derivatives Clearing Summit
Embracing challenges and assessing the impact of OTC derivatives clearing reform
Following on the success of the last year's inaugural event Risk magazine is proud to host its 2nd OTC Derivatives Clearing Summit in New York!
This year's event will focus on the impact of the new regulations on the OTC derivatives market, the challenges met during the implementation stage and issues that need urgent response from the regulators. This one-day summit is a must-attend gathering for industry professionals involved in OTC derivatives trading: it aims to assist with fundamental changes, address difficulties and help fully benefit from the market's increased transparency and industry forward thinking.
Risk's OTC Derivatives Clearing Summit conference will cover a number of topics, including:
- The regulatory update: Where is the OTC derivatives market now?
- The impact of the new regulations on costs and margining: How do the market participants react to changes?
- What is the future of futures?
- Clearing in practice: What systems and tools are available to meet Dodd-Frank requirements?
- Long-term implications of OTC clearing initiatives: Reduction or increase of the counterparty risk exposure?
- Collateral management procedures and funding challenges
- SEFs' state of readiness
- Cross-border issues: US vs. non-US regulations
...and many more!
Join us in Risk's OTC Derivatives Clearing Summit and gain invaluable insight on the OTC derivatives reform, and how to manage expected and unexpected challenges in the greatly altered derivatives industry!
Speakers confirmed:
Regulatory keynote address: Jeanmarie Davis, Senior Vice President, Financial Market Infrastructure, FEDERAL RESERVE BANK OF NEW YORK
Regulatory keynote address: Jennifer Marietta-Westberg, Deputy Director and Deputy Chief Economist, SECURITIES AND EXCHANGE COMMISSION
- Richard Mazzella, Chief Operating Officer Global Fixed Income & Mortgages, CITADEL
- David Olsen, Managing Director, Head of OTC Clearing, JP MORGAN
- Raymond Kahn, Managing Director, Head of OTC Derivatives Clearing, BARCLAYS
- Piers Murray, Managing Director, Global Head of Fixed Income Prime Brokerage, DEUTSCHE BANK
- Jack Bishop, Portfolio Manager, PRINCIPAL
- Robert Burke, Managing Director, Head of Global OTC Clearing, BANK OF AMERICA MERRILL LYNCH
- Louis Thorne, Managing Director, Chief Operating Officer, FORTRESS
- Rebecca Strutton, Director and Associate General Counsel, NEW YORK LIFE
- Judson Baker, Senior Vice President of OTC Derivatives Services, NORTHERN TRUST
- Jay Caggiano, Managing Director, Portfolio Manager, BABSON CAPITAL
- Ronald Filler, Professor of Law, NEW YORK LAW SCHOOL
- Garry O'Connor, Managing Director, Head of OTC Clearing, RBS MARKETS AND INTERNATIONAL BANKING
- Joseph Koltisko, Managing Director, Investments Group, NEW YORK LIFE
- Kampoleak Pal, Director, Derivatives Risk Management, Investments, GUARDIAN LIFE
- Supurna VedBrat , Managing Director, Co-head Electronic Trading & Market Structure, BLACKROCK
- Garry O'Connor, Managing Director, Head of OTC Clearing, RBS MARKETS AND INTERNATIONAL BANKING
- Michael Herskovitz, SVP Fixed Income Risk Operations and Co-Head Operational Risk Management, ALLIANCEBERNSTEIN
- Atanas Goranov, Managing Director, Derivatives Officer, GUARDIAN LIFE
- Edward Berliner, Managing Director, Counterparty Regulatory Strategy, BANK OF AMERICA
- Steven Mahoney, Managing Director, CREDIT SUISSE
- Ross Parke, Director, BARCLAYS CAPITAL
To enquire about speaking opportunities, please contact:
Justyna Topczewska, conference producer
justyna.topczewska@incisivemedia.com
